Ëèòåðàòóðà

ø8ß8^è³³òï[³øòà³ìøãìø[³³³²³³³³,³òøøèï³¹³ã»à-~ -ó >> Èíôåêöèîííûå áîëåçíè:  íàöèîíàëü

íîå ðóêîâîäñòâî. Ïîä ðåä. Í.Ä. Þùóêà, Þ.ß. Âåíãåðîâà. Ì: ÃÝÎÒÀÐ-Ìåäèà, 2009.

Ì.À. Ïàëüöåâà, Â.Ñ. Ïàóêîâà, Ý.Ã. Óëóìáå- êîâà. Ì.: ÃÝÎÒÀÐ-Ìåäèà, 2002: 146-161. Ïèíåãèí Á.Â. Ñîâðåìåííûå ïðåäñòàâëåíèÿ î ñòèìóëÿöèè àíòèèíôåêöèîííîãî èììóíèòåòà ñ ïîìîùüþ èììóíîìîäóëèðóþùèõ ïðåïàðàòîâ. Àíòèáèîò, è õèìèî- òåð. 2000; 1-2: 3-8. Ïðàêòè÷åñêîå ðóêîâîäñòâî ïî àíòèèíôåêöèîííîé õèìèîòåðàïèè. Ïîä ðåä. Ë.Ñ. Ñòðà÷óíñêîãî, Þ.Á. Áåëîóñîâà, Ñ.Í. Êîçëîâà. Ñìîëåíñê: ÌÀÊÌÀÕ, 2007. Ðàöèîíàëüíàÿ àíòèìèêðîáíàÿ ôàðìàêîòåðàïèÿ. Ïîä ðåä. Â.Ï. ßêîâëåâà, Ñ.Â. ßêîâëåâà. Ì.: Ëèòòåððà, 2003. Ñàïèí Ì.Ð., Íèêèòèí Ä.Á. Èììóííàÿ ñèñòåìà, ñòðåññ è èììóíîäåôèöèò. Ì.: ÀÏÏ «Äæàíãàð», 2000. Ñåïèàøâèëè Ð.È. Îñíîâû ôèçèîëîãèè èììóííîé ñèñòåìû. Ì.: Ìåäèöèíà-Çäîðîâüå, 2003. Òàóøíèö Ð. Àíòèáàêòåðèàëüíàÿ õèìèîòåðàïèÿ. Ì.: Óíèâåðñóì Ïàáëèøèíã, 1999. Õàèòîâ Ð.Ì.

È. Ã. Èììóíîëîãèÿ. Ì.: Ìåäèöèíà, 2002. Õàèòîâ Ð.Ì., Ïèíåãèí Á.Â. Ñîâðåìåííûå ïðåäñòàâëåíèÿ î çàùèòå îðãàíèçìà îò èíôåêöèè. Èììóíîëîãèÿ 2000; 1: 61-64. Öàðåâ Â.Í. Ðàçðàáîòêà ïðèíöèïîâ êîìïëåêñíîé èììóíî-áàêòåðèîëîãè÷åñêîé äèàãíîñòèêè è èììóíîìîäóëèðóþùåé òåðàïèè âîñïàëèòåëüíûõ çàáîëåâàíèé ÷åëþñòíî-ëèöåâîé îáëàñòè: Àâòîðåô. äèñ. ... ä-ðà ìåä. íàóê. Ì., 1992. Öàðåâ Â.Í. Àíòèìèêðîáíàÿ òåðàïèÿ â ñòîìàòîëîãèè: Ðóêîâîäñòâî. Ì.: Ìåäèöèíñêîå èíôîðìàöèîííîå àãåíòñòâî, 2006. ßðèëèí À.À. Îñíîâû èììóíîëîãèè. Ì.: Ìåäèöèíà, 1999. Abbas À,Ê., Lichiman À.Í., Pillai S.

al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006; 44: 34-43. Antoniades C.G., Berry P.A., Wendon J.A., Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J. Hepatol. 2008; 49: 845-861. Antunez C., Fernandez T., Bianca-Lopez N. et al. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response. Immediate hypersensitivity reactions to penicillins and other betalactams. Curr. Pharm. Des. 2006; 12: 3327-3333. Arnaiz-Villena A., Timon M., Rodriguez- Gallego C. Human T-cell activation deficiencies. Immunol. Today 1992; 13: 184-189. Arning M., Kliche K.O., Heer-Sonderhoff A.H., Wehmeier A. Infusion-related toxicity of three different amphotericin  formulations and its relation to cytokine plasma levels. Mycoses 1995; 38: 459-465. Bag inski M., Czub J., Sternal K. Interaction of amphotericin  and its selected derivatives with membranes: molecular modeling studies. Chem. Rec. 2006; 6: 320-332. Baginski M., Sternal K., Czub J., Borowski E. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic. Acta Biochim. Pol. 2005; 52: 655-658. Bauhofer A., Huff el M., Lorenz W. et at. Differential effects of antibiotics in combination with G-CSF on survival and polymorphonuclear granulocyte cell functions in septic rats. BMC Infect. Dis. 2008; 8: 55. Bendtzen K., Diamant M., Faber V. Fusid- ic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine 1990; 2: 423-429. Benjamin/' E., Sunshine G., Leskowitz S. Immunology, a short course. New York: WI- LEY-LISS, 1996.

¥ Bergogne-Berezin E. Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing.

Specification of the immune response: its suppression induced by chloramphenicol in vitro. Biosci. Rep. 1983; 3: 19-29. Cui W., Lei M.G., Silverstein R., Morrison C. Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria. J. Endotoxin. Res. 2003; 9: 225-236. Culic O., Erakovic V., Parnham M.J. Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol. 2001; 429(1-3): 209-229. Doric M., AbramM., Rukavina T. Antimicrobial activity and immunological side effects of different antibiotics. Folia Biol. (Praha) 1993; 39: 162-165. Doroszkiewicz W., Cisowska A., Jankowski S. et al. The susceptibility of gram-negative rods and their adaptive forms resistant

to colistine to the bactericidal action of sera. Acta Microbiol. Pol. 1998; 47: 275-281. Dugnani S., Demartini G., Triscari F., Fra- schini F.

Antibiotics and immunity: effects of antibiotics on natural killer, antibody dependent cell-mediated cytotoxicity and antibody production. Chemioterapia 1987; 6: 426-430. Ibrahim M.S., Maged Z.A., Haron A. et al. Antibiotics and immunity: effects of antibiotics on mitogen responsiveness of lymphocytes and interleukin-2 production. Chemioterapia 1988; 7: 369-372. Kadota J., Mizunoe S., Kishi K. et al. Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int. J. Antimicrob. Agents 2005; 25: 216-220. Kalish R.S., Koujak S. Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chlo- roquine at therapeutic concentrations. Clin Immunol. 2004; 113: 270-277. Kenny M.T., Balistreri F.J., Torney H.L. beta-Lactam antibiotic modulation of murine neutrophil cytokinesis. Immunopharmacol. Immunotoxicol. 1992; 14: 797-811. Kodama N.. Yamada M., Nanba H. Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn. J. Pharmacol. 2001; 87: 327-332. Kohyama T., Takizawa H., Kawasaki S. etal.

Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob. Agents Chemother. 1999; 43: 907-911. Kristian S.A., Timmer A.M., Liu G.Y. et al.

Impairment of innate immune killing mechanisms by bacteriostatic antibiotics. FASEB

J.  2007; 21: 1107-1116. Kumar S., Chakrabarti R. Amphotericin  both inhibits and enhances T-cell proliferation: inhibitory effect is mediated through H(2)0(2) production via cyclooxygenase pathway by macrophages. J. Cell Biochem. 2000; 77: 361-371. Kuzin Li., Snyder J.E., Ugine G.D. etal. Tetracyclines inhibit activated  cell function. Int. Immunol. 2001; 13: 921-931. Kyianpaa M.L., Meniula P., Kemppainen E.

et al. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas 2005; 31: 23-27. Labro M.T. Experimental evaluation of antibiotics as immunomodulators. J. Chemother. 1994; 6: 11-15. Labro M.T. Antibacterial agents—phagocytes: new concepts for old in immunomod- ulation. Int. J. Antimicrob. Agents. 1998; 10: 11-21. Labro M.T. Immunological effects of mac- rolides. Curr. Opin. Infect. Dis. 1998; 11: 681— 688. Langelot M., Cellerin L., Germaud P. Antiinflammatory effects of macrolides: applications in lung disease. Rev. Pneumol. Clin. 2006; 62: 215-222. Laval A., Viso M., Berhanu A., Kerveillant- Lenoire S. Immunomodulator effects of 2 antibiotics, chloramphenicol and kitasamy- cin, in the chicken. Ann. Rech. Vet. 1988; 19: 259-266. Lebrec H., Bachot N., Gaspard I. ef al.

Mechanisms of drug-induced allergic contact dermatitis. Cell Biol. Toxicol. 1999; 15: 57-62. Lefkowifh J.B. Leukocyte migration in immune complex glomerulonephritis: role of adhesion receptors. Kidney Int. 1997; 51: 1469-1475. Lipnick R.N., lliopoulos A., Salata K. ef al.

Leukocyte adhesion deficiency: report of a case and review of the literature. Clin. Exp. Rheumatol. 1996; 14: 95-98. Litfle J.R., Abegg A., Pluf E. The relationship between adjuvant and mitogenic effects

¥ of amphotericin methyl ester. Cell Immunol. 1983; 78: 224-235. Livermore D.M. Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 2009; 64: 29-36. Mandell L.A., Afnan M. Mechanisms of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophils, and gram-negative bacilli. Antimicrob. Agents Chemother. 1991; 35: 1291-1297. MelzerN., Meuth S.G., Torres-Salazar D. et

al. A beta-lactam antibiotic dampens excito- toxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS One. 2008; 3: 3149. Meroni P.L. Immune response to antibiotics in patients with secondary immunodeficiencies. J. Chemother. 1994; 6: 16-18. Ìîä³ T., Kita K. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol. Life Sci. 2009 [Epub ahead] Moore L.J., Gilbey A.M., Dowson C.G. et al. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta- lactam antibiotics. J. Antimicrob. Chemother. 2007; 59: 35-42. Morikawa K., Oseko F., Morikawa S., Iwa- moto K. Immunomodulatory effects of three macrolides, midecamycin acetate, josa- mycin, and clarithromycin, on human T- lymphocyte function in vitro. Antimicrob. Agents Chemother. 1994; 11: 2643-2647. MossP., Rosenberg W., BellJ. The human T cell receptor in health and disease. Ann. Rev. Immunol. 1992; 10: 71-78. Nahoum V., SpectorS., Loll P.J. Structure of ristocetin A in complex with a bacterial cell- wall mimetic. Acta Crystallogr. D. Biol. Crys- tallogr. 2009; 65: 832-838. Nualart P., Sen L., Estevez M.E., Diez R.A. Inhibition of E-and EAC-rosette formation by gentamicin, ampicillin and tetracycline. Biomed. Pharmacother. 1985; 39: 187-191. Nubile G., Tresca E., Di Profio E. et al. Effects of aminoglycosides on T and  lymphocyte populations: in vitro study. Quad. Scla- vo. Diagn. 1985; 21: 130-134.

Ortega ª., de Pablo M.A., Gaforio J.J. et

al. Modification of acquired immunity in BALB/c mice by aztreonam. Int. J. Antimi- crob. Agents 2000; 15:193-199. Oyama N., Sudo N., Sogawa H., Kubo C. Antibiotic use during infancy promotes a shift in the T(H)1/T(H)2 balance toward T(H)2-dominant immunity in mice. J. Allergy Clin. Immunol. 2001; 107: 153-159. Padovan E., von Greyerz S., Pichler W.J., Weltzien H.U. Links Antigen-dependent and -independent IFN-gamma modulation by penicillins. J. Immunol. 1999; 162: 1171— 1177. Pasquale T.R., TanJ.S. Nonantimicrobial effects of antibacterial agents. Clin. Infect. Dis. 2005; 40: 127-135. Paul W. Interleukin-4: a prototypic immu- noregulatory lymphokine. Blood 1991; 77: 1859-1865. Rahman M.U., Mazumder A. The immunomodulatory effects of gentamicin, imipen- em, piperacillin and amphotericin  on LAK effector function in vitro. FEMS Immunol. Med. Microbiol. 2001; 30: 249-252. Rama Iniguez S., Dea-Ayuela /VI.A., San- chez-Brunete J.A. et al. Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin  formulation. Antimicrob. Agents Chemother. 2006; 50: 1195-1201. Raskova H., Zidek Z. Surprises and omissions in toxicology. Cent Eur. J. Public Health 2004; 12: 94-96. Reth M.  cell antigen receptors. Curr. Opin. Immunol. 1994; 6: 3-14. Rodriguez A.B., Barriga C., De la Puente M.

Mechanisms of action involved in the chemoattractant activity of three beta-lactam- ic antibiotics upon human neutrophils. Bio- chem. Pharmacol. 1991; 41: 931-936. Rodriguez A.B., Pedrera M.I., Barriga C. In vivo effect of teicoplanin and vancomycin upon haemolytic and bactericidal activity of serum against Staphylococcus aureus. Comp. Immunol. Microbiol. Infect. Dis. 1996; 19: 283-288. Roitt I., Brostoff J., Mail D. Immunology. Edinburgh, London, New York: Harcourt Publishes Ltd., 2001. Romano A., Bousquet-Rouanef L., Viola M.

et al. Benzylpenicillin skin testing is still important in diagnosing immediate hypersensitivity reactions to penicillins. Allergy 2009; 64: 249-253. Roszkowski W., KoH.L., Roszkowski K. etal.

Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin. Med. Microbiol. Immunol. 1985; 173: 279-289.

WOSahin G., Akay O.M., Kus E. et al. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients. Ren. Fail. 2009; 31: 111-117.

101.5ancf/er C., Ekokoski £., Lindstedt K.A. etal.

Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells: possible involvement of protein kinase C. Inflamm. Res. 2005; 54: 304-312.

102Sandler C., Nurmi K., Lindstedt K.A. et al.

Chemically modified tetracyclines induce apoptosis in cultured mast cells. Int. Immu- nopharmacol. 2005; 5: 1611-1621.

103.Sau K., Mambula S.S., Latz E. et al. The antifungal drug amphotericin  promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem. 2003; 278: 37561-37568. 104.Savage C.O.S., Rees A. J. Role of neutrophils in vasculitis. In: Immunopharmacology of neutrophils. Ed. by P.G. Hellewell, T.J. William. London: Academic Press, 1994: 259273.

105.Shimomura H., Matsuura M., Saito S. et al.

Unusual interaction of a lipopolysaccha- ride isolated from Burkholderia cepacia with polymyxin B. Infect. Immunol. 2003; 71: 5225-5230.

106.S/evers E.L., Dale D.C. Non-malignant neutropenia. Blood Rev. 1996; 10: 95-100.

107.Simon D.M., Koenig G., Trenholme G.M.

Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J. Infect. Dis. 1991; 164: 800-802.

108.Smifh-Norowitz T.A., Bluth M.H., Drew H. et

al. Effect of minocycline and doxycycline on IgE responses. Ann. Allergy Asthma Immunol. 2002; 89: 172-179.

109.So/omon A., Rosenblatt M., Li D.Q. et al.

Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest. Ophthalmol. Vis. Sci. 2000; 41: 2544-2557.

110.Steel C., Wan Q., Xu X.H. Single live cell imaging of chromosomes in chloramphenicol-induced filamentous Pseudomonas aeruginosa. Biochemistry 2004; 43: 175-182. 111.Sudo N., Yu X.N., Aiba Y. et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin. Exp. Allergy 2002; 32: 1112-1116.

112.Sugiyama K., Shirai R., ÌèêຠH. et al. Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin. Exp. Immunol. 2007; 147: 540-546. Tamura M., Nagano Y. Modulation by polymyxin  of the effects of interferon on human myelogenous leukemia cells. Microbiol. Immunol. 1994; 38: 407-411. Targowski T. [Immunomodulating properties of antibiotics], Pol Merkur. Lekarski. 2004; 16: 88-90. Thrasher A. J., Keep N.H., Wientjes F., Segal A.W. Chronic granulomatous disease. Bio- chim. Biophys. Acta. 1994; 1227: 1-24. Torfoss D., Hoiby E.A., Holfe H., Kvaloy S.

Penicillin and aminoglycoside in febrile neutropenia. Tidsskr. Nor. Laegeforen. 2008; 128: 2738-2740. Van den Bogert C., Metis T.E., Kroon A.M.

Mitochondrial biogenesis during the activation of lymphocytes by mitogens: the immunosuppressive action of tetracyclines. J. Leuk. Biol. 1989; 46: 128-133. Van Langevelde P., Ravensbergen E., Grashoff P. et al. Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes. Antimicrob. Agents Chemother. 1999; 43: 2984-2989. Van Vlem B., Vanholder R., De Paepe P. et al. Immunomodulating effects of antibiotics: literature review. Infection 1996; 24: 275-291. Villa M.L., Rappocciolo G., Piazza P., Cleri- ci E. The interference of antibiotics with antigen-specific antibody responses in man. Int. J. Immunopharmacol. 1986; 8: 805-809. VioraM., De Luca A., D'Ambrosio A. etal. In vitro and in vivo immunomodulatory effects of anti-Pneumocystis carinii drugs. Antimicrob. Agents Chemother. 1996; 40:1294-1297. Von/: A.G., Netea M.G., Denecker N.E. et al. Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B. J. Antimicrob. Chemother. 1998; 42: 469-474. Williams F.M. Role of neutrophils in reperfusion injury. In: Immunopharmacology of neutrophils. Ed. by P.G. Hellewell, T.J. Williams. London: Academic Press, 1994: 245-257.

124 .Wulansari R., Wijaya A., Ano H. et al. Lymphocyte subsets and specific IgG antibody levels in clindamycin-treated and untreated dogs experimentally infected with Babesia gibsoni. J. Vet. Med. Sci. 2003; 65: 579-584. Yokota T. Kinds of antimicrobial agents and their mode of actions. Nippon. Rinsho. 1997; 55: 1155-1160. Zhao C., Ling Z., Newman M.B. et al. TNF- alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis. 2007; 26: 36-46.